ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $86,000 | -22.5% | 59,138 | -23.9% | 0.00% | – |
| Q4 2016 | $111,000 | +20.7% | 77,752 | +47.5% | 0.00% | – |
| Q3 2016 | $92,000 | +1.1% | 52,708 | 0.0% | 0.00% | – |
| Q2 2016 | $91,000 | -12.5% | 52,708 | 0.0% | 0.00% | – |
| Q1 2016 | $104,000 | +3.0% | 52,708 | -0.1% | 0.00% | – |
| Q4 2015 | $101,000 | -2.9% | 52,787 | 0.0% | 0.00% | – |
| Q3 2015 | $104,000 | -55.9% | 52,787 | 0.0% | 0.00% | – |
| Q2 2015 | $236,000 | +24.2% | 52,787 | +25.1% | 0.00% | – |
| Q1 2015 | $190,000 | +68.1% | 42,195 | +30.4% | 0.00% | – |
| Q4 2014 | $113,000 | -16.3% | 32,356 | 0.0% | 0.00% | – |
| Q3 2014 | $135,000 | – | 32,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |